J, H., EY, B., S, C., & J, L. (2025). The value-for-money assessment and funding arrangements for high-priced drugs in an era of uncertainty: A comparative analysis of national health technology assessment agencies in South Korea, England, Australia, and Canada. BMC health services research, 25(1), 74. https://doi.org/10.1186/s12913-025-12207-9
Chicago Style (17th ed.) CitationJ, Hong, Bae EY, Cha S, and Lee J. "The Value-for-money Assessment and Funding Arrangements for High-priced Drugs in an Era of Uncertainty: A Comparative Analysis of National Health Technology Assessment Agencies in South Korea, England, Australia, and Canada." BMC Health Services Research 25, no. 1 (2025): 74. https://doi.org/10.1186/s12913-025-12207-9.
MLA (9th ed.) CitationJ, Hong, et al. "The Value-for-money Assessment and Funding Arrangements for High-priced Drugs in an Era of Uncertainty: A Comparative Analysis of National Health Technology Assessment Agencies in South Korea, England, Australia, and Canada." BMC Health Services Research, vol. 25, no. 1, 2025, p. 74, https://doi.org/10.1186/s12913-025-12207-9.